MedPath

NAINA MOHAMED & SONS PRIVATE LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

48

HSA:48

Drug Approvals

COXIB-200 CAPSULES 200MG

Approval Date
Oct 22, 2020
HSA

PANTOTAB GASTRO RESISTANT TABLETS 40 MG

Approval Date
Dec 2, 2019
HSA

CLARIWIN 500 FILM COATED TABLET 500MG

Approval Date
Jul 30, 2019
HSA

Angizaar-50mg Tablet

Approval Date
Nov 2, 2009
HSA

MICROFLOX-500 TABLET 500 mg

Approval Date
Sep 14, 2002
HSA

FEBCID-40 TABLET 40 mg

Approval Date
Jul 31, 2002
HSA

HIPRIL-5 TABLET 5 mg

Approval Date
Jul 30, 2002
HSA

CLARIWIN-250 TABLET 250 mg

Approval Date
Jul 30, 2002
HSA

SIMVAS-10 TABLET 10 mg

Approval Date
May 25, 2002
HSA

ERYCYN-250 TABLET 250 mg

Approval Date
May 25, 2002
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.